What Is Hexafluoropropylene Oxide Dimer Acid?

Hexafluoropropylene oxide dimer acid, usually called HFPO-DA or by its trade-associated name GenX, is a synthetic fluorinated chemical introduced as a supposedly safer replacement for PFOA, one of the most notorious “forever chemicals.”¹ Research over the past decade has complicated that safety narrative considerably, linking HFPO-DA to liver damage, kidney injury, immune disruption, and developmental problems in animal studies, while communities near manufacturing facilities have found it in their drinking water at worrying levels.

Why HFPO-DA Exists

Fluoropolymers like PTFE (the nonstick coating on cookware) need processing aids during manufacturing. For decades, that aid was the ammonium salt of PFOA. As evidence mounted that PFOA persists in the environment, accumulates in human blood, and causes health problems, the chemical industry agreed to phase it out. Chemours, a spinoff of DuPont, replaced PFOA with the ammonium salt of HFPO-DA for PTFE production.² The logic was straightforward: HFPO-DA has a shorter carbon chain and an ether linkage in its backbone, which should make it less persistent in living organisms than PFOA. That turned out to be partly true and partly misleading, as the chemical still belongs to the broader family of per- and polyfluoroalkyl substances (PFAS) and shares many of the structural features that make PFAS so resistant to breakdown in the environment.

How It Spreads Through the Environment

HFPO-DA enters the environment primarily through air emissions and wastewater discharges from fluoropolymer manufacturing plants. Atmospheric modeling of the Chemours facility in Fayetteville, North Carolina, showed that air concentrations of GenX near the plant can reach roughly 25 nanograms per cubic meter but drop to about 0.1 nanograms per cubic meter at 35 kilometers downwind. Only about 2.5% of the total GenX emitted settles within 150 kilometers of the facility; the rest gets carried farther out.³ That means the chemical doesn’t just stay near its source. It travels.

Once deposited, HFPO-DA makes its way into groundwater. A study modeling private well contamination near the same North Carolina facility found that the strongest predictors of whether a well exceeded the state health goal of 140 nanograms per liter were air deposition rates, distance from the facility, prevailing wind direction, well depth, and soil characteristics. Other potential sources like landfills and wastewater treatment plants did not improve the model’s predictions, suggesting that for communities near a fluoropolymer plant, airborne deposition is the dominant pathway into drinking water.⁴ Discovery of high concentrations in the Cape Fear River and in finished drinking water serving more than 200,000 North Carolina residents forced rapid action from regulators, water utilities, and researchers.⁵

What It Does to the Liver

The liver is the organ most consistently harmed by HFPO-DA in animal studies. Much of this damage runs through a receptor called PPARα, which regulates fat metabolism. When HFPO-DA activates PPARα in mice, the result is liver enlargement, increased cell turnover, and tissue injury. Experiments using mice that lack PPARα showed significantly less liver damage after GenX exposure, confirming that this receptor is a key driver of the toxic effects.⁶ An earlier study found that GenX activated mouse PPARα in laboratory assays, and the resulting gene changes aligned with the liver swelling, increased cell division, and cell death seen in treated animals.⁷

Here is where the science gets complicated. Mice rely heavily on PPARα for liver metabolism, and the relevance of mouse PPARα findings to human health has been debated for decades. Some researchers argue that this pathway is far less active in human livers, which would make the mouse liver effects a poor guide to human risk. The same study that identified PPARα as the driver explicitly noted that this pathway “has limited relevance to humans.”⁸ But other research suggests the picture is not so reassuring. When PPARα was knocked out in mice, HFPO-DA still caused liver enlargement, which means additional pathways beyond PPARα are involved.⁹

A mouse drinking-water study exposed animals to HFPO-DA at concentrations ranging from environmental levels (0.1 and 10 micrograms per liter) up to much higher doses. Even at the lower environmental concentrations, researchers reported impaired liver function, elevated blood lipids, liver fibrosis, inflammation, and dose-dependent increases in early cancer biomarkers.¹⁰ That study described HFPO-DA as a potential carcinogen, though it is worth noting that the findings come from a single laboratory in mice, and no human cancer data exist yet.

Kidney Damage and Blood Effects

The liver gets most of the attention, but the kidneys are also a target. Reviews of subchronic and chronic animal studies report that HFPO-DA treatment increased kidney weight in both mice and rats, with increases up to about 16% in males and 23% in females at various dose levels. Those weight changes came alongside elevated blood urea nitrogen, a marker of kidney stress, and chronic exposure produced visible kidney damage including tissue overgrowth, swelling, mineral deposits, and in some cases tissue death.¹¹

How the kidneys handle HFPO-DA is itself an active research question. The chemical needs to be transported into and out of kidney cells by specific proteins. One study found that HFPO-DA was a likely substrate for several kidney transporters in both humans and rats, including human OAT3 and rat Oat1. The interaction with transporters on different sides of the kidney cell membrane suggests the chemical could be both actively secreted and partially reabsorbed, which would affect how quickly the body clears it.¹² However, a separate study using a different set of transporters found that HFPO-DA was not transported by any of the three renal transporters they examined.¹³ The disagreement likely reflects the different specific transporters tested in each study, but it highlights how much remains uncertain about exactly how HFPO-DA moves through the human body.

Immune System Effects

PFAS chemicals in general have been linked to immune suppression, and HFPO-DA appears to follow that pattern in some respects while showing its own quirks. A lung exposure study in mice found that GenX suppressed the innate immune response. When mice were exposed to both GenX and carbon black nanoparticles (a model lung irritant), GenX significantly reduced the influx of infection-fighting neutrophils and dampened production of a key immune signaling molecule compared to nanoparticle exposure alone.¹⁴ In practical terms, this means the chemical may blunt the body’s first-line defense against inhaled particles and pathogens.

Work using human blood cells has added another dimension. Exposing human immune cells to PFAS including HFPO-DA led to reduced B-cell identity and lower expression of antibody genes, while simultaneously increasing T-cell activation and proliferation.¹⁵ That combination, weakened antibody production alongside overactive T-cell responses, resembles the kind of immune imbalance that can impair vaccine effectiveness and increase susceptibility to infections, though direct evidence of those outcomes in people exposed to HFPO-DA has not yet been established.

Developmental and Reproductive Risks

Some of the most concerning findings involve pregnancy and fetal development. In rats exposed to HFPO-DA during gestation, both maternal and fetal livers showed strong activation of PPAR-related genes in a dose-dependent pattern, with 16 of the same genes turned up in both mothers and their fetuses.¹⁶ Exposed mothers gained more weight during pregnancy, but their pups were born smaller in both body weight and length, and developmental delays in weight, length, and tail growth persisted through the first three weeks of life. Examination of the placentas revealed immune-cell infiltration and congestion, and protein analysis pointed to inflammation through a specific signaling pathway.¹⁷

Mice studies have shown a similar pattern. At a dose of 10 milligrams per kilogram per day, GenX-treated mice had significantly heavier placentas but lower embryo-to-placenta weight ratios, suggesting the placentas were swollen or dysfunctional rather than more robust.¹⁸ More recent research has shown that HFPO-DA exposure can shift placental metabolism toward a less efficient energy pattern, with tissue damage that worsens with dose.¹⁹ These placental findings matter because a compromised placenta can explain how a chemical harms a developing fetus without crossing into fetal tissue in large amounts.

How It Compares to PFOA

The whole point of HFPO-DA was to be safer than PFOA. In some narrow respects, it is. It has a shorter carbon chain, and it clears from the human body faster. But “faster” is relative. In a community exposed through contaminated drinking water in North Carolina, the estimated half-lives for related fluoroether compounds ranged from roughly 127 to 379 days.²⁰ Those numbers are shorter than PFOA’s estimated half-life of two to three years but still far from trivial. A compound that takes months to leave your body after each exposure, with new exposure arriving daily through tap water, can still build up.

In terms of toxic potency, the comparison is sobering. A zebrafish study found that while HFPO-DA required a higher external concentration to kill half the embryos than PFOA did, once the researchers accounted for how much each chemical actually got inside the fish, the internal concentrations causing harm were nearly identical for both compounds. PFOA’s internal effect concentration was about 226 micromolar and GenX’s was about 229 micromolar, suggesting essentially equal toxic potency once the chemicals reach their targets.²¹ The replacement, in other words, may be less bioaccumulative but not less toxic at equivalent internal doses.

Does It Build Up in Wildlife?

One of the claimed advantages of HFPO-DA is lower bioaccumulation potential. A dietary study in a bottom-feeding fish found that while PFOA and PFOS accumulated as expected when fed to the fish, GenX did not appear to bioaccumulate at all, either because the fish did not absorb it through the gut or because it was eliminated within 24 hours.²² That sounds encouraging, but the picture changes in a different species. Tilapia exposed through water rather than food did accumulate GenX in their tissues, with the chemical concentrating most in blood plasma and liver. Muscle tissue showed the longest half-life at over 1,200 hours. And salinity mattered: fish in brackish water accumulated more than those in fresh water, raising concerns for marine species and for people who eat saltwater fish from contaminated areas.²³

The takeaway is that bioaccumulation depends heavily on the species, the exposure route, and environmental conditions. Blanket claims that HFPO-DA does not accumulate in wildlife are too simple.

Can It Be Removed From Water?

Treating HFPO-DA in drinking water is technically feasible but challenging. Conventional water treatment processes like chlorination and standard filtration do not break down fluorinated chemicals. Among the options that do work, adsorption is the most accessible for water utilities. Comparing granular activated carbon, powdered activated carbon, and anion-exchange resins, researchers found that a weakly basic anion-exchange resin (IRA67) had the highest adsorption capacity for GenX at about 3.2 millimoles per gram, roughly four times more effective than either type of activated carbon.²⁴ That matters for homeowners considering point-of-use filters: standard carbon filters will catch some GenX, but ion-exchange systems are substantially better.

For destroying the chemical rather than just capturing it, electrochemical oxidation shows promise. Using a boron-doped diamond electrode, researchers achieved nearly complete mineralization of GenX, breaking it down into carbon dioxide and fluoride. The key finding was that the commonly used hydroxyl radicals were essentially unreactive toward HFPO-DA, which is unusual for organic pollutants. Instead, direct electron transfer at the electrode surface and electrochemically activated sulfate were the effective pathways.²⁵ Follow-up work pairing a graphene-coated cathode with a boron-doped diamond anode achieved about 92% removal of total organic carbon, but confirmed that hydroxyl radicals alone managed only 9% mineralization, underscoring how resistant this molecule is to conventional advanced oxidation.²⁶

Thermal Destruction and Incineration

High-temperature incineration is sometimes proposed as a catch-all for PFAS waste. For HFPO-DA, computational modeling predicts that the molecule begins breaking apart at around 700 kelvin (about 427°C or 800°F) at the residence times typically used in incinerators.²⁷ The decomposition initially sheds hydrogen fluoride and carbon dioxide, then fragments further into smaller fluorinated pieces. More detailed simulations have shown that water plays a critical role: at furnace temperatures around 650°C, the breakdown products of GenX stall as perfluorinated aldehydes unless water is present to catalyze their further hydrolysis into carbon dioxide and hydrogen fluoride.²⁸ This means dry incineration could generate harmful fluorinated byproducts rather than fully destroying the chemical. Complete mineralization requires both high temperatures and sufficient moisture.

Detecting HFPO-DA in Water

One practical challenge with HFPO-DA is that it was not included in standard PFAS monitoring panels for years after it entered the environment. Standard methods for measuring legacy PFAS like PFOA did not automatically capture GenX because of its different chemical structure. Newer analytical techniques using liquid chromatography paired with tandem mass spectrometry can now detect GenX in water at concentrations as low as 1 nanogram per liter, using small sample volumes of only 1.5 milliliters and total processing times under an hour.²⁹ That sensitivity matters because health-based guidelines are set in the low nanograms-per-liter range. The U.S. EPA’s final drinking water standard for HFPO-DA, finalized in 2024, set a maximum contaminant level of 10 nanograms per liter, which is far below what older methods could reliably measure. Communities concerned about their water now have access to laboratory methods that can detect these levels, but testing still requires specialized equipment and is not something a standard home water test kit can accomplish.

Salinity, Species, and Why Context Matters for Risk

A recurring theme across HFPO-DA research is that context dramatically changes the results. Salinity affects how much fish accumulate. The route of exposure (eating contaminated food versus absorbing it through water) changes whether organisms build up the chemical at all. The species of test animal determines which receptors are activated and how relevant the liver findings are to people. Even the presence or absence of moisture in an incinerator determines whether the chemical is fully destroyed or merely converted into different fluorinated fragments.

For people living near fluoropolymer manufacturing sites, the most direct concern is drinking water. If you rely on a private well within a few dozen kilometers of such a facility, testing for HFPO-DA and related fluoroether acids is worth the expense, particularly if you are downwind. Municipal water systems in affected areas have generally been required to address the contamination, but private well owners typically bear responsibility for their own testing and treatment. Ion-exchange filtration systems rated for PFAS removal are the most effective household option based on current evidence.